Business Office Feature

Technology Feature | Agreeable antibodies: Antibody validation challenges and solutions

See allHide authors and affiliations

Science  15 Sep 2017:
Vol. 357, Issue 6356, pp. 1165-1167
DOI: 10.1126/science.357.6356.1165

Summary

Commercially produced antibodies have become workhorses of basic research, but opaque supply chains, a lack of clear quality standards, and scientists' complacency have turned antibody-based experiments into potential disaster zones. Several strategies can help researchers navigate past these pitfalls.